CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Net income (loss)	$ 37,134,631	$ (2,459,571)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation expense	8,260	8,502
Gain on debt extinguishment	(40,802,730)	(2,434,661)
Decrease in fair value of derivative liabilities	0	(618)
Amortization of discount on notes payable	1,261,156	1,447,400
Accrued interest on patents purchased	0	123,233
Amortization of patents and acquired contracts	776,745	811,989
Stock-based compensation	249,020	393,456
Changes in operating assets and liabilities
Accounts receivable	14,824	4,966
Prepaid expenses and other current assets, net	452,017	(24,140)
Deferred expenses	97,409	(34,877)
Accounts payable	78,701	(384,683)
Accrued expenses and other current liabilities	185,077	405,555
Deferred revenue	(1,246,429)	300,000
Net cash used in operating activities	(1,791,319)	(1,843,449)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs	0	2,425,000
Proceeds from issuance of common stock, net of issuance costs	0	1,182,278
Proceeds from short-term notes payable, related party	385,000	0
Payments on senior notes payable	0	(1,640,016)
Payments on related party note payable	0	(50,000)
Net cash provided by financing activities	385,000	1,917,262
Net increase (decrease) in cash and cash equivalents	(1,406,319)	73,813
Cash and cash equivalents, beginning of period	1,476,774	554,556
Cash and cash equivalents, end of period	70,455	628,369
Supplemental disclosures of cash flow information
Cash paid for interest	0	426,249
Supplemental disclosures of non-cash investing and financing activities
Fair value of common stock warrants	$ 341,535	$ 1,481,978